FOXM1 and cancer: Conversely, inhibition of FOXM1 leads to reduced proliferation, migration, and metastasis of cancer cells, and FOXM1 is strongly correlated with clinicopathological features of stem cell-related in NPC tissues, such as late clinical stage, tumor recurrence, and distant metastasis.